…
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -62.42M | -24.86M | -30.40M | -15.85M | -4.71M |
| Minority interest | 0.70M | 0.11M | -0.39M | 0.44M | 0.54M |
| Net income | -86.71M | -29.51M | -32.47M | -17.73M | -4.96M |
| Selling general administrative | 23.98M | 32.78M | 14.71M | 11.85M | 6.99M |
| Selling and marketing expenses | 0.63M | 7.39M | 1.03M | 1.93M | - |
| Gross profit | 6.06M | 24.61M | 5.14M | 8.49M | 2.89M |
| Reconciled depreciation | 9.52M | 6.39M | 6.17M | 4.15M | 0.08M |
| Ebit | -28.73M | -22.82M | -17.30M | -10.91M | -4.63M |
| Ebitda | -19.20M | -16.41M | -11.11M | -6.60M | -4.55M |
| Depreciation and amortization | 9.53M | 6.41M | 6.19M | 4.32M | 0.08M |
| Operating income | -28.73M | -22.82M | -17.30M | -10.91M | 2.81M |
| Other operating expenses | 97.83M | 75.01M | 60.43M | 46.60M | 25.97M |
| Interest expense | 8.72M | 4.76M | 2.81M | 1.82M | 0.08M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | 0.01M | 0.01M | 0.02M | 0.16M | 0.08M |
| Net interest income | -8.71M | -4.75M | -2.79M | -1.66M | -0.00M |
| Income tax expense | 24.29M | 4.65M | 2.07M | 1.88M | -7.19M |
| Total revenue | 69.10M | 52.20M | 43.13M | 35.69M | 21.26M |
| Total operating expenses | 34.78M | 47.42M | 22.44M | 19.40M | 7.60M |
| Cost of revenue | 63.05M | 27.59M | 37.99M | 27.20M | 18.37M |
| Total other income expense net | -33.70M | -2.04M | -13.10M | -4.94M | -7.52M |
| Net income from continuing ops | -62.42M | -24.86M | -30.40M | -15.85M | -4.71M |
| Net income applicable to common shares | -61.73M | -24.75M | -29.66M | -15.91M | -4.96M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 100.45M | 72.64M | 68.60M | 56.96M | 19.06M |
| Intangible assets | 18.15M | 9.59M | 5.74M | 6.21M | - |
| Other current assets | 2.52M | 1.91M | 1.15M | 1.91M | 1.64M |
| Total liab | 131.04M | 56.05M | 65.72M | 34.02M | 4.42M |
| Total stockholder equity | -28.34M | 17.33M | 3.28M | 22.50M | 14.10M |
| Other current liab | 6.70M | 0.04M | 14.27M | 3.67M | 2.19M |
| Common stock | 114.12M | 98.41M | 60.13M | 50.19M | 26.88M |
| Capital stock | 114.12M | 98.41M | 60.13M | 50.19M | 26.88M |
| Retained earnings | -147.02M | -85.29M | -60.20M | -30.44M | -14.53M |
| Other liab | - | - | 0.20M | - | - |
| Good will | 7.69M | 6.75M | 3.71M | 3.71M | - |
| Cash | 1.62M | 10.70M | 18.81M | 7.95M | 9.38M |
| Total current liabilities | 37.15M | 18.53M | 27.67M | 13.18M | 4.24M |
| Current deferred revenue | - | 3.81M | 0.18M | - | - |
| Net debt | 105.91M | 33.99M | 25.39M | 17.77M | -9.02M |
| Short term debt | 13.64M | 7.16M | 6.35M | 4.88M | 0.18M |
| Short long term debt | 2.52M | 0.60M | 1.18M | 0.17M | 0.18M |
| Short long term debt total | 107.54M | 44.69M | 44.20M | 25.71M | 0.36M |
| Other stockholder equity | 4.55M | 4.20M | 3.35M | 2.76M | 1.75M |
| Property plant equipment | 55.56M | 31.44M | 28.48M | 27.10M | 0.91M |
| Total current assets | 19.04M | 24.86M | 30.67M | 19.95M | 18.15M |
| Net tangible assets | -54.19M | 0.99M | -6.18M | 12.59M | 14.10M |
| Net receivables | 13.90M | 11.00M | 10.71M | 10.09M | 7.13M |
| Long term debt | 52.09M | 13.05M | 15.10M | 0.15M | 0.18M |
| Inventory | 1.00M | 1.25M | - | - | - |
| Accounts payable | 16.81M | 7.52M | 6.87M | 4.64M | 1.87M |
| Non current assets total | 81.40M | 47.78M | 37.93M | 37.01M | 0.91M |
| Capital lease obligations | 52.93M | 31.03M | 27.91M | 25.39M | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | 0.17M | -15.14M | -0.20M | -8.13M | -0.81M |
| Change to liabilities | 5.61M | 0.25M | 2.51M | 2.95M | 1.86M |
| Total cashflows from investing activities | 0.17M | -15.14M | 0.02M | -9.25M | -0.81M |
| Net borrowings | 14.87M | -5.77M | 13.37M | -3.54M | -2.79M |
| Total cash from financing activities | 3.97M | 24.42M | 19.01M | 15.25M | 16.06M |
| Change to operating activities | 0.20M | -0.33M | 0.74M | 0.15M | -0.16M |
| Net income | -62.42M | -24.86M | -30.40M | -15.85M | -4.71M |
| Change in cash | -9.08M | -7.06M | 10.86M | -1.43M | 7.85M |
| Begin period cash flow | 10.70M | 17.76M | 7.95M | 9.38M | 1.53M |
| End period cash flow | 1.62M | 10.70M | 18.81M | 7.95M | 9.38M |
| Total cash from operating activities | -13.21M | -16.34M | -7.95M | -8.55M | -7.40M |
| Issuance of capital stock | 0.00M | 35.11M | 9.94M | 20.60M | 18.89M |
| Depreciation | 9.52M | 6.39M | 6.17M | 4.15M | 0.08M |
| Other cashflows from investing activities | 0.26M | -0.19M | 0.25M | -1.11M | -1.11M |
| Dividends paid | 0.00M | 0.00M | 0.00M | - | - |
| Change to account receivables | 0.83M | -0.29M | -0.62M | -2.96M | -5.03M |
| Other cashflows from financing activities | 44.11M | -4.91M | 13.78M | -0.06M | 0.28M |
| Change to netincome | 32.36M | 2.39M | 12.91M | 3.06M | 0.80M |
| Capital expenditures | 0.03M | 0.03M | 0.03M | 0.84M | 0.81M |
| Change in working capital | 6.63M | -0.37M | 2.64M | 0.14M | -3.32M |
| Stock based compensation | 0.35M | 0.88M | 0.59M | 0.69M | 0.47M |
| Other non cash items | 32.71M | 4.75M | 13.05M | 2.31M | 0.09M |
| Free cash flow | -13.25M | -16.37M | -7.95M | -9.39M | -8.21M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare, Inc. |
-12.49 2.46% |
494.99 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-3.13 1.09% |
283.33 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.06 0.42% |
14.62 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.28 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. William P. Leonard | Pres, CEO & Director | 1965 |
| Mr. Erns Loubser C.A., C.F.A. | CFO & Treasurer | 1985 |
| Ms. Diana Shi | Sr. VP of Operations | 1985 |
| Ms. Euphia Hsu Smith | Chief Marketing Officer | 1972 |
| Benjamin Klein | Chief Exec. Officer | NA |
| Glen Akselrod | Investor Relations Officer | NA |
| Ms. Iris Krug | VP of Compliance & Privacy Officer | NA |
| Ms. Brittany Schwemmer | VP of HR | NA |
| Dr. Geoffrey Grammer M.D. | Chief Medical Officer | 1971 |
| Mr. Sasha Cucuz | Executive Chairman | 1979 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.